Record Index Results
Search
Contents
Download
Documentation
About MassBank
News Archive
Index Type :
MS Type:
MS3
Back to Record Index
Results :
929 Hit.
( 94 - 139 Displayed )
First
Prev
1
2
3
4
5
6
7
8
9
10
Next
Last
( Total
13
Page )
▼
Results End
Name
Formula / Structure
ExactMass
ID
Eserine
2 spectra
C15H21N3O2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
275.16339
LC-ESI-IT; MS3; m/z: 276/162; [M+H]+
MSBNK-Keio_Univ-KO008960
LC-ESI-IT; MS3; m/z: 276/219; [M+H]+
MSBNK-Keio_Univ-KO008959
Etodolac
1 spectrum
C17H21NO3
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
287.15213
LC-ESI-IT; MS3; m/z: 288/172; [M+H]+
MSBNK-Keio_Univ-KO008957
Fenfluramine
1 spectrum
C12H16F3N
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
231.12347
LC-ESI-IT; MS3; m/z: 232/187; [M+H]+
MSBNK-Keio_Univ-KO009108
Ganciclovir
1 spectrum
C9H13N5O4
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
255.09676
LC-ESI-IT; MS3; m/z: 256/152; [M+H]+
MSBNK-Keio_Univ-KO008990
Glu-Glu
4 spectra
C10H16N2O7
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
276.09576
LC-ESI-IT; MS3; m/z: 277/221; [M+H]+
MSBNK-Keio_Univ-KO008974
LC-ESI-IT; MS3; m/z: 277/235; [M+H]+
MSBNK-Keio_Univ-KO008973
LC-ESI-IT; MS3; m/z: 277/241; [M+H]+
MSBNK-Keio_Univ-KO008972
LC-ESI-IT; MS3; m/z: 277/259; [M+H]+
MSBNK-Keio_Univ-KO008971
Glycocholic acid
2 spectra
C26H43NO6
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
465.30905
LC-ESI-IT; MS3; m/z: 466/355; [M+H]+
MSBNK-Keio_Univ-KO008977
LC-ESI-IT; MS3; m/z: 466/373; [M+H]+
MSBNK-Keio_Univ-KO008976
Glycyrrhetinic acid
7 spectra
C30H46O4
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
470.33960
LC-ESI-IT; MS3; m/z: 471/189; [M+H]+
MSBNK-Keio_Univ-KO008985
LC-ESI-IT; MS3; m/z: 471/217; [M+H]+
MSBNK-Keio_Univ-KO008984
LC-ESI-IT; MS3; m/z: 471/235; [M+H]+
MSBNK-Keio_Univ-KO008983
LC-ESI-IT; MS3; m/z: 471/263; [M+H]+
MSBNK-Keio_Univ-KO008982
LC-ESI-IT; MS3; m/z: 471/317; [M+H]+
MSBNK-Keio_Univ-KO008981
LC-ESI-IT; MS3; m/z: 471/407; [M+H]+
MSBNK-Keio_Univ-KO008980
LC-ESI-IT; MS3; m/z: 471/425; [M+H]+
MSBNK-Keio_Univ-KO008979
Guanosine
1 spectrum
C10H13N5O5
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
283.09167
LC-ESI-IT; MS3; m/z: 284/152; [M+H]+
MSBNK-Keio_Univ-KO008967
Harmaline
3 spectra
C13H14N2O
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
214.11061
LC-ESI-IT; MS3; m/z: 215/174; [M+H]+
MSBNK-Keio_Univ-KO008997
LC-ESI-IT; MS3; m/z: 215/198; [M+H]+
MSBNK-Keio_Univ-KO008996
LC-ESI-IT; MS3; m/z: 215/200; [M+H]+
MSBNK-Keio_Univ-KO008995
Hyoscyamine
1 spectrum
C17H23NO3
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
289.16779
LC-ESI-IT; MS3; m/z: 290/124; [M+H]+
MSBNK-Keio_Univ-KO008999
Kanamycin
1 spectrum
C18H36N4O11
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
484.23807
LC-ESI-IT; MS3; m/z: 485/324; [M+H]+
MSBNK-Keio_Univ-KO009015
Ketamine
2 spectra
C13H16ClNO
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
237.09204
LC-ESI-IT; MS3; m/z: 238/179; [M+H]+
MSBNK-Keio_Univ-KO009116
LC-ESI-IT; MS3; m/z: 238/220; [M+H]+
MSBNK-Keio_Univ-KO009115
Kynurenine
1 spectrum
C10H12N2O3
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
208.08479
LC-ESI-IT; MS3; m/z: 209/192; [M+H]+
MSBNK-Keio_Univ-KO009017
L(+)-Cystathionine
1 spectrum
C7H14N2O4S
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
222.06743
LC-ESI-IT; MS3; m/z: 223/134; [M+H]+
MSBNK-Keio_Univ-KO008911
L-Anserine
3 spectra
C10H16N4O3
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
240.12224
LC-ESI-IT; MS3; m/z: 241/109; [M+H]+
MSBNK-Keio_Univ-KO008822
LC-ESI-IT; MS3; m/z: 241/170; [M+H]+
MSBNK-Keio_Univ-KO008821
LC-ESI-IT; MS3; m/z: 241/224; [M+H]+
MSBNK-Keio_Univ-KO008820
L-Carnosine
3 spectra
C9H14N4O3
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
226.10658
LC-ESI-IT; MS3; m/z: 227/110; [M+H]+
MSBNK-Keio_Univ-KO008901
LC-ESI-IT; MS3; m/z: 227/156; [M+H]+
MSBNK-Keio_Univ-KO008900
LC-ESI-IT; MS3; m/z: 227/180; [M+H]+
MSBNK-Keio_Univ-KO008899
L-Glutathione (oxidized form)
2 spectra
C20H32N6O12S2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
612.15198
LC-ESI-IT; MS3; m/z: 613/355; [M+H]+
MSBNK-Keio_Univ-KO008988
LC-ESI-IT; MS3; m/z: 613/484; [M+H]+
MSBNK-Keio_Univ-KO008987
L-Homocarnosine
1 spectrum
C10H16N4O3
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
240.12224
LC-ESI-IT; MS3; m/z: 241/156; [M+H]+
MSBNK-Keio_Univ-KO008992
Leupeptin
1 spectrum
C20H38N6O4
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
426.29544
LC-ESI-IT; MS3; m/z: 427/367; [M+H]+
MSBNK-Keio_Univ-KO009039
Levomepromazine
2 spectra
C19H24N2OS
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
328.16092
LC-ESI-IT; MS3; m/z: 329/242; [M+H]+
MSBNK-Keio_Univ-KO009125
LC-ESI-IT; MS3; m/z: 329/284; [M+H]+
MSBNK-Keio_Univ-KO009124
Lidocaine
1 spectrum
C14H22N2O
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
234.17320
LC-ESI-IT; MS3; m/z: 235/86; [M+H]+
MSBNK-Keio_Univ-KO009035
Loperamide
1 spectrum
C29H33ClN2O2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
476.22305
LC-ESI-IT; MS3; m/z: 477/266; [M+H]+
MSBNK-Keio_Univ-KO009037
Lumichrome
2 spectra
C12H10N4O2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
242.08038
LC-ESI-IT; MS3; m/z: 243/172; [M+H]+
MSBNK-Keio_Univ-KO009023
LC-ESI-IT; MS3; m/z: 243/200; [M+H]+
MSBNK-Keio_Univ-KO009022
Mefenamic acid
1 spectrum
C15H15NO2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
241.11028
LC-ESI-IT; MS3; m/z: 242/224; [M+H]+
MSBNK-Keio_Univ-KO009074
Melatonin
1 spectrum
C13H16N2O2
Generated by the Chemistry Development Kit (http://github.com/cdk)
\n
232.12119
LC-ESI-IT; MS3; m/z: 233/174; [M+H]+
MSBNK-Keio_Univ-KO009066
First
Prev
1
2
3
4
5
6
7
8
9
10
Next
Last
( Total
13
Page )
▲
Results Top
Imprint
Data Privacy
Feedback
system version 2.2.7
Copyright © 2006 MassBank Project; 2011
NORMAN Association
; 2021
MassBank Consortium